Tanios Bekaii-Saab, MD

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Agios
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Arys
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Arcus
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Atreca
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Boston Biomedical
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bayer
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eisai
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Celgene
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lilly
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ipsen
    Topic:
    Research Funding (to institution)
    Date added:
    08/05/2024
    Date updated:
    08/08/2024

Pages

Return to Southwest Hematology Oncology Conference: Precision Guided Therapy